Skip to main content

TD PRIVATE CLIENT WEALTH LLC

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1551017 NEW YORK, NY

Position in REGN

as of Jun 30, 2026 · filed Aug 4, 2026
Position Value
$93,531
-$37,817 QoQ
Shares Held
150
-11.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,068
of 1,297 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

TD PRIVATE CLIENT WEALTH LLC holds $2,695,967 across 45 Biotechnology names. REGN ranks #5 (3.5% of the industry book) .

# Ticker Company Shares Value (USD) Open
5 REGN
Regeneron Pharmaceuticals, Inc.
This page
150 $93,531

All Filings in REGN

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $93,531 150
2026-03-31 $131,348 170
2025-12-31 $130,446 169
2025-09-30 $86,589 154
2025-06-30 $56,700 108
2025-03-31 $80,547 127
2024-12-31 $121,808 171
2024-09-30 $163,993 156
2024-06-30 $156,603 149
2024-03-31 $151,110 157
2023-12-31 $120,325 137
2023-09-30 $108,630 132
2023-06-30 $97,721 136
2023-03-31 $119,963 146
2022-12-31 $102,451 142
2022-09-30 $102,641 149
2022-06-30 $68,571 116
2022-03-31 $109,651 157
2021-12-31 $84,623 134
2021-09-30 $58,097 96
2021-06-30 $157,508 282
2021-03-31 $118,285 250
2020-12-31 $80,679 167
2020-09-30 $115,314 206
2020-06-30 $144,063 231
2020-03-31 $121,584 249